Comans Tracy A, Nguyen Kim-Huong, Mulhern Brendan, Corlis Megan, Li Li, Welch Alyssa, Kurrle Susan E, Rowen Donna, Moyle Wendy, Kularatna Sanjeewa, Ratcliffe Julie
The Centre for Health Services Research, University of Queensland, Brisbane, Queensland, Australia.
NHMRC's Partnership Centre on Dealing with Cognitive and Related Functional Decline in Older People, Sydney, New South Wales, Australia.
BMJ Open. 2018 Jan 21;8(1):e018996. doi: 10.1136/bmjopen-2017-018996.
Generic instruments for assessing health-related quality of life may lack the sensitivity to detect changes in health specific to certain conditions, such as dementia. The Quality of Life in Alzheimer's Disease (QOL-AD) is a widely used and well-validated condition-specific instrument for assessing health-related quality of life for people living with dementia, but it does not enable the calculation of quality-adjusted life years, the basis of cost utility analysis. This study will generate a preference-based scoring algorithm for a health state classification system -the Alzheimer's Disease Five Dimensions (AD-5D) derived from the QOL-AD.
Discrete choice experiments with duration (DCE) and best-worst scaling health state valuation tasks will be administered to a representative sample of 2000 members of the Australian general population via an online survey and to 250 dementia dyads (250 people with dementia and their carers) via face-to-face interview. A multinomial (conditional) logistic framework will be used to analyse responses and produce the utility algorithm for the AD-5D.
The algorithms developed will enable prospective and retrospective economic evaluation of any treatment or intervention targeting people with dementia where the QOL-AD has been administered and will be available online. Results will be disseminated through journals that publish health economics articles and through professional conferences. This study has ethical approval.
用于评估健康相关生活质量的通用工具可能缺乏检测特定疾病(如痴呆症)健康变化的敏感性。阿尔茨海默病生活质量量表(QOL-AD)是一种广泛使用且经过充分验证的针对特定疾病的工具,用于评估痴呆症患者的健康相关生活质量,但它无法计算质量调整生命年,而质量调整生命年是成本效用分析的基础。本研究将为源自QOL-AD的健康状态分类系统——阿尔茨海默病五维度量表(AD-5D)生成一种基于偏好的评分算法。
将通过在线调查对2000名澳大利亚普通人群的代表性样本以及通过面对面访谈对250对痴呆症患者(250名痴呆症患者及其照料者)进行离散选择实验(DCE)和最佳-最差尺度健康状态评估任务。将使用多项(条件)逻辑框架来分析回答并生成AD-5D的效用算法。
所开发的算法将能够对任何针对接受过QOL-AD评估的痴呆症患者的治疗或干预进行前瞻性和回顾性经济评估,并且将在网上提供。研究结果将通过发表健康经济学文章的期刊以及专业会议进行传播。本研究已获得伦理批准。